Next Article in Journal
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
Next Article in Special Issue
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme
Previous Article in Journal
Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers
Previous Article in Special Issue
Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(2), 412; https://doi.org/10.3390/pharmaceutics15020412
Action Date Notes Link
article pdf uploaded. 26 January 2023 09:52 CET Version of Record https://www.mdpi.com/1999-4923/15/2/412/pdf-vor
article supplementary file uploaded. 26 January 2023 09:52 CET - https://www.mdpi.com/1999-4923/15/2/412#supplementary
article xml file uploaded 14 February 2023 07:28 CET Original file -
article xml uploaded. 14 February 2023 07:28 CET Update https://www.mdpi.com/1999-4923/15/2/412/xml
article pdf uploaded. 14 February 2023 07:28 CET Updated version of record https://www.mdpi.com/1999-4923/15/2/412/pdf
article html file updated 14 February 2023 07:29 CET Original file -
article html file updated 14 February 2023 07:32 CET Update -
article html file updated 8 March 2023 02:23 CET Update https://www.mdpi.com/1999-4923/15/2/412/html
Back to TopTop